Evidence map›Paper›PMID 20623307›Full record

ArticleJournal of molecular modeling2011

Molecular modeling and dynamics simulation of a histidine-tagged cytochrome b₅.

Ying-Wu Lin, Tian-Lei Ying, Li-Fu Liao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ying-Wu LinSchool of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, People's Republic of China. linlinying@hotmail.com
Tian-Lei Ying
Li-Fu Liao
University of South China · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although an affinity tag such as six consecutive histidines, (His)(6)-tag, has been widely used to obtain high quantity of recombinant proteins, little is known about its influences on heme proteins for lack of structural information. When (His)(6)-tag was introduced to the N-terminus of a small heme protein, cytochrome b(5), experimental results showed the resultant protein, (His)(6)-cyt b(5), has similar property and function to that of isolated cyt b(5). To provide structural information for this observation, we herein performed a structural prediction of (His)(6)-cyt b(5) by molecular modeling in combination with molecular dynamics simulation. The predicted structure, as assessed by a series of criteria with good quality, reveals that the (His)(6)-tag adopts a helical conformation and packs against the hydrophobic core 2 of cyt b(5) through salt bridges, hydrogen bonding and hydrophobic interactions. The heme group, with the axial His ligands slightly rotated, was found to have similar conformation as in isolated cyt b(5), which indicates that the N-terminal (His)(6)-tag does not alter the heme active site, resulting in similar dynamics properties for core 1. This study provides valuable information of interactions between (His)(6)-tag and the rest of the protein, aiding in rational design and application of functional His-tagged proteins.

Indexed as

Crystallography, X-RayCytochromes b5HemeHistidineHydrophobic and Hydrophilic InteractionsLigandsModels, ChemicalMolecular Dynamics SimulationNuclear Magnetic Resonance, BiomolecularOligopeptidesProtein Structure, SecondaryRecombinant ProteinsCytochromes b5HemeHis-His-His-His-His-HisHistidineLigandsOligopeptidesRecombinant Proteins

Identifiers

PMID20623307
OpenAlexW1988336841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.